-+ 0.00%
-+ 0.00%
-+ 0.00%

ALVOTECH AND ADVANZ PHARMA ANNOUNCE FIRST KNOWN REGULATORY SUBMISSION WORLDWIDE FOR PROPOSED BIOSIMILAR TO EYLEA® 8 MG

Reuters·10/14/2026 08:30:23

Please log in to view news